Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SMAD1/5 binding regions and expression data of human umbilical vein endothelial cells (HUVECs) and pulmonary arterial smooth muscle cells (PASMCs) treated with BMPs

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

OTHER RELATED OMICS DATASETS IN: PRJNA143113PRJNA138481PRJNA143115PRJNA141765PRJNA141767

ORGANISM(S): Homo sapiens

PROVIDER: GSE27661 | GEO | 2011/07/16

SECONDARY ACCESSION(S): PRJNA138481

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

SMAD1/5 binding regions of human pulmonary arterial smooth muscle cells (PASMCs) treated with BMP

Project description:Smad1/5 are transcription factors that engage in BMP-induced transcription. We determined and analyzed Smad1/5 binding sites by ChIP-sequencing. We used expression microarrays to compare the Smad1/5 binding sites identified by ChIP-seq to BMP-induced gene expressions.

2011-07-16 | GSE28848 | GEO

SMAD1/5 binding regions of human umbilical vein endothelial cells (HUVECs) treated with BMP.

Project description:Smad1/5 binding regions were identified by ChIP-seq.

2011-07-16 | GSE27634 | GEO

SMAD1/5 binding regions of human umbilical vein endothelial cells (HUVECs) treated with BMP.

Project description:Smad1/5 binding regions were identified by ChIP-seq. HUVECs were treated with BMP for 1.5 h and anti-SMAD1/5 ChIP-seq analyses were performed using Illumina genome analyzer.

2011-07-15 | E-GEOD-27634 | biostudies-arrayexpress

Primary human umbilical vein and arterial endothelial cells

Project description:Human umbilical cords were obtained from the Lucille Packard Children Hospital. In this study, we devised a rapid isolation scheme to preserve the in vivo phenotype of each endothelial subtype. ECs were first isolated from umbilical cords by collagenase perfusion through the vein or artery as described. Cells were further purified using a Percoll density gradient (Amersham Biosciences, Piscataway, NJ) to remove residual erythrocytes and platelets. 1-5 x 106 ECs were then cultured overnight on gelatin-coated T12.5 flasks in Clonetics EGM-2 media (Cambrex Bio Science, Walkersville, MD) in which the ECs generally reached confluence the next morning. The confluent EC were trypsinized and subjected to two rounds of immuno-magnetic beads purification, adapted from a published purification protocol. There was a negative selection step using CD14, CD45 and CD64 to remove residual contaminating leukocytes, followed by positive selection using a mouse anti-endothelial cell monoclonal antibody (anti-CD146/clone P1H12 purchased from Chemicon, Temecula, CA). Total processing time was limited to 20 to 24 hours. The homogeneous, viable, primary ECs were used immediately to construct the library. The construction of SAGE libraries was performed with the I-SAGE kit (Invitrogen, Carlsbad, CA) per manufacturer’s instructions Keywords: other

2009-12-31 | GSE1539 | GEO

Primary human umbilical vein and arterial endothelial cells

2009-12-30 | E-GEOD-1539 | biostudies-arrayexpress

Human umbilical vein endothelial cells (HUVECs) treated with fenofibrate

Project description:This SuperSeries is composed of the SubSeries listed below.

2009-08-24 | GSE15494 | GEO

Expression data of human pulmonary arterial smooth muscle cells (PASMCs) treated with BMP-4

2011-07-15 | E-GEOD-28847 | biostudies-arrayexpress

Human umbilical vein endothelial cells (HUVECs) treated with fenofibrate

Project description:This SuperSeries is composed of the following subset Series: GSE15482: The effect of PPARa siRNA on endothelial cells treated with fenofibrate GSE15483: The effect of fenofibrate on endothelial cells Refer to individual Series

2009-08-24 | E-GEOD-15494 | biostudies-arrayexpress

Cytoprotective Effects and Mechanisms of ?-17 Fatty Acid Desaturase in Injured Human Umbilical Vein Endothelial Cells (HUVECs).

Project description: Not available

| S-EPMC5388310 | biostudies-literature

Vascular injury post stent implantation: different gene expression modulation in human umbilical vein endothelial cells (HUVECs) model.

Project description: Not available

| S-EPMC3935971 | biostudies-literature